PATH Vaccine Solutions: Clinical Trials

3 trials sponsored by PATH Vaccine Solutions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow PATH Vaccine Solutions: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine
SIIL LAIV (live, trivalent seasonal influenza vaccine), Placebo - Influenza
Phase 2CompletedPATH Vaccine Solutions3092012-06-012015-06-01
Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults
Placebo, SPWCV+Alum 100 mcg, SPWCV+Alum 600 mcg - Pneumococcal Vaccines
Phase 1CompletedPATH Vaccine Solutions422012-02-012014-06-05
Low-dose Challenge Model With Enterotoxigenic E Coli
E coli strain H10407 and buffer, E coli H10407 and buffer - Diarrhea
Phase 1CompletedJohns Hopkins Bloomberg School of Public Health302009-02-012014-09-12

Conditions studied

Diarrhea (1)  ·  Influenza, Human (1)

Interventions

Buffers (1)

Countries

United States (2)  ·  Bangladesh (1)

Top investigators

Clayton Harro, M.D. (1)  ·  Royce Morrison, M.D. (1)  ·  W. Abdullah Brooks, MD, MPH (1)

Results publications

PMID 21852546, PMID 29702652, PMID 30481269, PMID 30481272, PMID 30592459, PMID 31895881